2',2'-(Naphthalene-1,8-diyl)bis(1,1,3,3-tetramethylguanidine)

Catalog No. :
ACAECR783
CAS No. :
442873-72-5
Molecular Formula :
C20H30N6
Molecular Weight :
354.50

IUPAC Name:2,2'-(naphthalene-1,8-diyl)bis(1,1,3,3-tetramethylguanidine)

2',2'-(Naphthalene-1,8-diyl)bis(1,1,3,3-tetramethylguanidine) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$231.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2',2'-(Naphthalene-1,8-diyl)bis(1,1,3,3-tetramethylguanidine)
IUPAC Name2,2'-(naphthalene-1,8-diyl)bis(1,1,3,3-tetramethylguanidine)
MDL No.MFCD06798180
Molecular FormulaC20H30N6
Molecular Weight354.50
SMILESCN(C)C(=NC1=CC=CC2=C1C(N=C(N(C)C)N(C)C)=CC=C2)N(C)C
InChI KeyPSHHYQWGIGYWHP-UHFFFAOYSA-N
Synonym1,1,2,3-tetramethyl-3-[8-[methyl-(N,N,N'-trimethylcarbamimidoyl)amino]naphthalen-1-yl]guanidine | SCHEMBL2137423 | DTXSID10630610 | (1,8-bis(tetramethylguanidino)naphthalene) | E80353 | N,N'-Naphthalene-1,8-diylbis(N,N',N',N''-tetramethylguanidine)
CAS No.442873-72-5

Safety Data

Pictogram
Toxic
Signal Word
Gefahrenhinweise
Hazard Statement(s)
H301-H311-H331
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACAECR783 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNYBS941 route compound structure diagram
    ACNYBS941632-22-4 In Stock
  4. Then
  5. ACAECR783 route product structure diagram
    ACAECR783442873-72-5
Inquiry

2. ACAECR783 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAECR783 route product structure diagram
    ACAECR783442873-72-5
Inquiry

Comments (0)